This bill would allow parents or guardians who hold health insurance policies to request information about controlled substances prescribed to their adult children who are enrolled as dependents on those plans. The legislation creates an exception to existing patient privacy rules under the Health Insurance Portability and Accountability Act, requiring health insurers and covered entities to disclose controlled substance prescription information when requested by the policyholder. However, the bill specifically protects medication-assisted treatment for substance use disorders from disclosure, meaning parents could not obtain information about prescriptions like methadone or buprenorphine used to treat addiction. The bill applies to controlled substances as defined under federal law and affects health insurers, health plans, and other covered healthcare entities. No specific funding or implementation timeline is included in the legislation, which was introduced in January 2024 and referred to the Senate Committee on Health, Education, Labor, and Pensions.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.